Biocon

MilliporeSigma | January 04, 2017

Merck, a leading life science and technology company, today announced it has acquired BioControl Systems Inc., a global leader in food safety testing. The acquisition opens growth opportunities for Merck in the food and beverage space; particularly in the U.S. Confidentiality has been agreed on the financial details of the transaction....

Novartis | January 18, 2018

Sandoz, a Novartis division and the global leader in biosimilars, today announced a global partnership with Asia's premier biopharmaceuticals company, Biocon, to develop, manufacture and commercialize multiple biosimilars in immunology and oncology for patients worldwide. Under the terms of the agreement, both companies will share responsibility for end-to-end development, manufacturing and global regulatory approvals for a number of products, and will have a cost and profit share arrangemen...

Pharmaphorum Media Limited | November 15, 2018

Cello’s US health consulting business Defined Health has been rebranded as Cello Health BioConsulting, following its acquisition by the group last year. Cello said the move was prompted by industry evolution and outlined how even the most scientifically-driven biotech companies need to think commercially sooner.Jon Bircher, CEO of Cello Health Consulting, said: “Since Defined Health joined the Cello Health family 18 months ago, we have spent significant time with our colleagues...

Questex LLC | December 13, 2018

Sanofi’s Lantus is already facing off against generic competition from Eli Lilly and Boehringer’s Basaglar, but now Mylan is adding to the pressure by prevailing in a patent challenge at the U.S. Patent and Trademark Office. The PTO’s Patent Trial and Appeal Board invalidated two Lantus formulation patents, knocking down one barrier to market for Mylan and its partner Biocon as their generic awaits a decision at the FDA. The partners still face a patent fight with Sanofi in cou...